MedTrace Logo

Efficacy of rTMS and tDCS as Adjunctive Rehabilitation for Cerebrovascular Disease-related Gait Dysfunction

NCT04282538 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-02-24

No results posted yet for this study

Summary

This study was a prospective, randomized, single-blind, parallel-controlled, multicenter clinical study to evaluate the efficacy and safety of repetitive transcranial magnetic stimulation and transcranial direct current stimulation assisted rehabilitation in the treatment of cerebrovascular disease-related gait disorders.

Conditions

  • Repetitive Transcranial Magnetic Stimulation
  • Transcranial Direct Current Stimulation
  • Cerebrovascular Disease
  • Gait Dysfunction, Neurologic

Interventions

DEVICE

Active rTMS

4-week (5 days per week) active rTMS (90%rMT, M1, 10Hz for 10s, 50s interval, 20 trains)

DEVICE

Sham rTMS

4-week (5 days per week) sham rTMS

DEVICE

Active tDCS

4-week (5 days per week) active tDCS (2mA, DLPFC, 20 min)

DEVICE

Sham tDCS

4-week (5 days per week) sham tDCS

OTHER

Walking training

4-week (5 days per week) walking training

OTHER

Cognition training

4-week (5 days per week) cognition training

Sponsors & Collaborators

  • zsneurology

    lead OTHER

Principal Investigators

  • Xin Wang, MD · Shanghai Zhongshan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2020-11-30
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04282538 on ClinicalTrials.gov